Abstract
Catheter-related bladder discomfort (CRBD) is an unrecognized clinical event. Symptoms of CRBD secondary to an indwelling urinary catheter mimic those of an overactive bladder, i.e. urinary frequency and urgency with or without urge incontinence. Stimulation of muscarinic receptors located in the bladder wall by the catheter is the triggering factor. Postoperative pain may be increased by the CRBD. Antimuscarinic drugs, as oxybutynin, are today the main treatment. Further studies are warranted to confirm efficacy of ketamine, tramadol and gabapentin in this situation.
Copyright © 2012 Société française d’anesthésie et de réanimation (Sfar). Published by Elsevier SAS. All rights reserved.
MeSH terms
-
Amines / therapeutic use
-
Anesthesia Recovery Period
-
Cyclohexanecarboxylic Acids / therapeutic use
-
Dysuria / drug therapy
-
Dysuria / etiology*
-
Dysuria / physiopathology
-
Female
-
Gabapentin
-
Humans
-
Ketamine / therapeutic use
-
Male
-
Mandelic Acids / therapeutic use
-
Muscarinic Antagonists / therapeutic use
-
Pain, Postoperative / drug therapy
-
Pain, Postoperative / etiology*
-
Pain, Postoperative / physiopathology
-
Receptors, Muscarinic / drug effects
-
Receptors, Muscarinic / physiology
-
Recovery Room*
-
Risk Factors
-
Severity of Illness Index
-
Symptom Assessment
-
Syndrome
-
Tramadol / therapeutic use
-
Urinary Catheterization / adverse effects*
-
Urothelium / injuries
-
Urothelium / physiopathology
-
gamma-Aminobutyric Acid / therapeutic use
Substances
-
Amines
-
Cyclohexanecarboxylic Acids
-
Mandelic Acids
-
Muscarinic Antagonists
-
Receptors, Muscarinic
-
Tramadol
-
gamma-Aminobutyric Acid
-
Ketamine
-
Gabapentin
-
oxybutynin